Corvus Pharmaceuticals | SCHEDULE 13G/A:其他
Corvus Pharmaceuticals | SCHEDULE 13G/A:其他
Corvus Pharmaceuticals | 8-K:重大事件
Corvus Pharmaceuticals | 4:持股变动声明-高管 MILLER RICHARD A MD
Corvus Pharmaceuticals | 4:持股变动声明-高管 LEA LEIV
Corvus Pharmaceuticals | 4:持股变动声明-高管 Jones William Benton
Corvus Pharmaceuticals | 4:持股变动声明-高管 Arcara Jeffrey
Corvus Pharmaceuticals | 8-K:重大事件
Corvus Pharmaceuticals | 10-Q:2024财年三季报
Corvus Pharmaceuticals | 8-K:Corvus Pharmicals提供最新业务并报告2024年第三季度财务业绩
Corvus Pharmaceuticals | 8-K:重大事件
Corvus Pharmaceuticals | EFFECT:其他
Corvus Pharmaceuticals | CORRESP:信函
Corvus Pharmaceuticals | UPLOAD:其他
Corvus Pharmaceuticals | S-3:特定交易注册声明
Corvus Pharmaceuticals | 10-Q:2024财年二季报
Corvus Pharmaceuticals | 8-K:Corvus Pharmicals提供最新业务并报告2024年第二季度财务业绩
Corvus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Samlyn Capital, LLC(9.99%),Samlyn, LP(9.99%)等
Corvus Pharmaceuticals | 4:持股变动声明-董事 Grais Linda
Corvus Pharmaceuticals | 4:持股变动声明-董事 CLARK IAN T